Cost effectiveness of stent implantation versus PTCA: the BENESTENT experience.
Semin Interv Cardiol
; 1(4): 263-8, 1996 Dec.
Article
en En
| MEDLINE
| ID: mdl-9552520
ABSTRACT
The aim of this paper is to assess the costs and effects of stent implantation versus percutaneous transluminal coronary angioplasty (PTCA). Data have been taken from both the BENESTENT-I and BENESTENT-II pilot study. Effects are expressed in terms of event-free survival and costs include those of the initial hospitalization and those during follow-up. The costs per additional event-free survivor after 7 months are estimated at Dfl 88,315, Dfl 28,127 and Dfl 6747 using respectively the results from the BENSTENT-I study, the BENESTENT-II pilot study and phase IV of the BENESTENT-II pilot study. Significant decreases in complications and ischaemic events have made stent implantation not only the most favourable in terms of event-free survival but also in terms of cost effectiveness.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
1_ASSA2030
Problema de salud:
1_financiamento_saude
Asunto principal:
Angioplastia Coronaria con Balón
/
Stents
/
Enfermedad Coronaria
/
Implantación de Prótesis Vascular
Tipo de estudio:
Clinical_trials
/
Health_economic_evaluation
/
Observational_studies
/
Prognostic_studies
Aspecto:
Patient_preference
Límite:
Humans
Idioma:
En
Revista:
Semin Interv Cardiol
Asunto de la revista:
CARDIOLOGIA
Año:
1996
Tipo del documento:
Article
País de afiliación:
Países Bajos